Disease Diagnosis TRIZ Cases

Metabolite biomarker analysis stratifies Alzheimer's disease subjects by sex and APOE genotype status.

Reagents detect human autoantibodies against specific proteins in bodily fluids to monitor breast cancer therapy efficacy.

A blood analyzer generates support information by integrating analysis data from multiple blood cell types to enhance diagnostic precision.

Measuring MIC-1 serum levels predicts prostate cancer progression and survival, replacing invasive biopsies to reduce unnecessary aggressive treatments.

Antibodies bind surrogate light chains to enable precise biomarker detection in clinical diagnostics.

Fluorescent microspheres conjugated with specific peptides detect anti-Zika antibodies via multiplex immunoassay.

Activated macrophages absorb brain marker proteins to enable peripheral detection of neurodegenerative conditions.

Fluorescent probes bind unbound bilirubin to measure toxic levels, resolving the contradiction between total bilirubin accuracy and neurotoxicity assessment.

Monoclonal antibody isolates citrullinated autoantigens to eliminate false positives from non-specific autoantibodies in rheumatoid arthritis testing.

Modular nanoparticles release detectable markers upon protease cleavage for affinity-based capture assays.

An inert reference antibody corrects therapeutic antibody concentrations in brain tissue samples by accounting for residual blood interference.

Mass spectrometry identifies kappa and lambda free light chains by mass-to-charge ratio, resolving monoclonal gammopathies from polyclonal backgrounds.

Mass spectroscopy analysis of culture media proteins selects viable embryos, reducing multiple pregnancy risks.

Segmented ELISA assays differentiate nitrated from total hemopexin to resolve measurement precision limits in sepsis diagnosis.

Segmented capture reagents detect low-abundance proteins to resolve sensitivity and complexity trade-offs in near-term prediction.

Antibody-mediated detection of Na/K-ATPase Y260 phosphorylation resolves measurement precision challenges to diagnose cancer via Src signaling assessment.

Segmented test zones within a capillary tube enable rapid pathogen detection, eliminating extended incubation times required by conventional planar assays.

Trained animal bio-sensors detect volatile organic compounds in breath samples, replacing invasive radiation procedures and reducing false positives.

An immunochromatography strip detects PBP2′ protein using labeled antibodies and capture reagents.

Measuring cMet-positive T cells enables early detection of cardiac inflammation before symptoms appear, resolving the timing bottleneck.

Analyzing perfusate fluid proteins during hypothermic perfusion to predict organ suitability and reduce ischemic reperfusion injury.

Boiling serum samples denatures interfering proteins before antibody binding, eliminating false positives and negatives in Aspergillus diagnosis.

Selective precipitation of sulfated glycosaminoglycans using dimethylmethylene blue at acidic pH separates free and associated fractions from biological samples.

Oral lysophosphatidyl compounds form eutectic mixtures with free fatty acids to reduce IKr channel inhibition and prevent drug-induced QT prolongation.

Monitoring galectin-3 levels guides patient selection for cardiac resynchronization therapy, reducing non-response rates.

Provocative chelation therapy removes maternal heavy metals, preventing birth defects and miscarriages.

FALD-GSH biomarkers enable non-invasive halogen gas exposure detection, replacing invasive biopsies with blood plasma analysis.

NT-proCNP plasma levels differentiate septic complications from trauma interference, enabling reliable early diagnosis and risk stratification.

Six-protein biomarker panels detect lung cancer early while reducing false positive rates from imaging.

Applying a specific procalcitonin threshold of 0.03 ng/ml improves diagnostic precision for pancreatic diabetes despite limited patient population adaptability.

An in vitro method measures seroreactivity against specific endothelial cell antigens to identify acute microvascular rejection.

Targeting non-linear epitopes between amino acids 157 and 255 resolves assay instability caused by proteolysis and storage variations.

Measuring phosphorylated neuronal nitric oxide synthase ratios enables early perinatal brain injury detection.

Anti-P2X receptor antibodies detect P2X7 receptors in extracellular body fluids, enabling non-invasive cancer diagnosis without tissue biopsies.

Analyzing polypeptide signatures differentiates bacterial from viral infections, reducing antibiotic misuse and resistance.

Hydroxyapatite-selective fluorescent dyes bind to retinal deposits and exhibit longer fluorescence lifetime signals compared to background tissue.

Analyzing Ki-67 protein concentrations in plasma or serum normalizes results against lymphocyte counts to accurately quantify total tumor load.

Repetitive low-intensity blast overpressure enhances amyloid beta clearance via LRP1-mediated transcytosis.

Disposable electrochemical test strips measure nitric oxide in exhaled breath, resolving the trade-off between measurement precision and device complexity.

Lateral flow dry stick measures haptoglobin via competitive immunological binding to enable early mastitis detection.

A diagnostic composition detects circulating osteocalcin-positive cells expressing N-cadherin in blood samples for early identification of bone metastasis.

Analyzing specific protein biomarkers overcomes static HDL-C measurement limitations to improve diagnostic accuracy for cardiovascular risk.

A serum biomarker panel detects chronic kidney disease stages using inflammatory and complement markers.

Immunoassay detects IgA, IgM, and IgG antibodies in saliva or serum samples to identify specific food sensitivities in companion animals.

IgD and IgM expression ratio predicts chronic lymphocytic leukemia clinical course.

Segmenting gut tissue sampling from peripheral blood analysis consolidates universal biomarker detection for personalized treatment planning.

Antigen compositions enable prophylaxis and treatment of babesiosis in immunocompromised individuals.

A micro-device separates diseased cells from normal ones by enhancing microscopic property differences.